Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Next Science Ltd ( (AU:NXS) ).
Next Science Limited has updated its previously announced cash return of capital for holders of its ordinary fully paid shares, advising that the payment date for the capital return has been amended. The revised timetable follows shareholder approval received on 28 January 2026 and is supported by documentation lodged with the ASX, signalling continued execution of the company’s capital management strategy and providing clarity to investors on the updated payment schedule.
The most recent analyst rating on (AU:NXS) stock is a Hold with a A$0.15 price target. To see the full list of analyst forecasts on Next Science Ltd stock, see the AU:NXS Stock Forecast page.
More about Next Science Ltd
Next Science Limited, listed on the ASX under the code NXS, is an Australian company with ordinary fully paid shares on issue. The company operates within the broader life sciences and medical technology sector, focusing on innovative treatments and technologies, and its securities are subject to standard ASX corporate action processes, including capital management initiatives such as returns of capital.
Average Trading Volume: 568,356
Technical Sentiment Signal: Sell
Current Market Cap: A$42.43M
For detailed information about NXS stock, go to TipRanks’ Stock Analysis page.